ATE517993T1 - Transkriptionsfaktor islet-brain 1 (ib1) - Google Patents
Transkriptionsfaktor islet-brain 1 (ib1)Info
- Publication number
- ATE517993T1 ATE517993T1 AT07019868T AT07019868T ATE517993T1 AT E517993 T1 ATE517993 T1 AT E517993T1 AT 07019868 T AT07019868 T AT 07019868T AT 07019868 T AT07019868 T AT 07019868T AT E517993 T1 ATE517993 T1 AT E517993T1
- Authority
- AT
- Austria
- Prior art keywords
- brain
- transcription factor
- glut2
- human
- disclosed
- Prior art date
Links
- 101710105206 C-Jun-amino-terminal kinase-interacting protein 1 Proteins 0.000 title abstract 4
- 102100022291 C-Jun-amino-terminal kinase-interacting protein 1 Human genes 0.000 title abstract 4
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 102000058058 Glucose Transporter Type 2 Human genes 0.000 abstract 2
- 101001046660 Homo sapiens C-Jun-amino-terminal kinase-interacting protein 1 Proteins 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 108091006299 SLC2A2 Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 101001046655 Rattus norvegicus C-Jun-amino-terminal kinase-interacting protein 1 Proteins 0.000 abstract 1
- 101100341613 Rattus norvegicus Mapk8ip1 gene Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 102000054579 human MAPK8IP1 Human genes 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108091006106 transcriptional activators Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706731.8A GB9706731D0 (en) | 1997-04-03 | 1997-04-03 | Transcription factor islet-brain (IBI) |
| GBGB9709920.4A GB9709920D0 (en) | 1997-05-15 | 1997-05-15 | Transcription factor islet-brain 1 (B1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE517993T1 true ATE517993T1 (de) | 2011-08-15 |
Family
ID=26311309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98913958T ATE382087T1 (de) | 1997-04-03 | 1998-04-02 | Transkriptionsfaktor islet-brain 1 (ib1) |
| AT07019868T ATE517993T1 (de) | 1997-04-03 | 1998-04-02 | Transkriptionsfaktor islet-brain 1 (ib1) |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98913958T ATE382087T1 (de) | 1997-04-03 | 1998-04-02 | Transkriptionsfaktor islet-brain 1 (ib1) |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5880261A (de) |
| EP (3) | EP0973895B1 (de) |
| AT (2) | ATE382087T1 (de) |
| AU (1) | AU6847298A (de) |
| DE (1) | DE69838905T2 (de) |
| DK (1) | DK0973895T3 (de) |
| ES (1) | ES2299205T3 (de) |
| PT (1) | PT973895E (de) |
| WO (1) | WO1998044106A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6043083A (en) * | 1997-04-28 | 2000-03-28 | Davis; Roger J. | Inhibitors of the JNK signal transduction pathway and methods of use |
| US20060019879A1 (en) * | 1998-07-31 | 2006-01-26 | El Shami A S | Polynucleotide encoding autoantigens associated with endometriosis |
| US6525187B1 (en) | 1998-07-31 | 2003-02-25 | Diagnostic Products Corporation | Polynucleotide encoding autoantigens associated with endometriosis |
| US20060019878A1 (en) * | 1998-07-31 | 2006-01-26 | El Shami A S | Polynucleotide encoding autoantigens associated with endometriosis |
| US6610820B1 (en) * | 1999-10-12 | 2003-08-26 | University Of Lausanne | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US20040082509A1 (en) | 1999-10-12 | 2004-04-29 | Christophe Bonny | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US20030108539A1 (en) * | 2000-02-14 | 2003-06-12 | Christophe Bonny | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US8183339B1 (en) | 1999-10-12 | 2012-05-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| US6716824B1 (en) * | 1999-10-22 | 2004-04-06 | F. Charles Brunicardi | Treatment of pancreatic adenocarcinoma by cytotoxic gene therapy |
| US7208581B1 (en) * | 1999-11-05 | 2007-04-24 | The Burnham Institute | TRAF family proteins |
| WO2001075159A2 (en) * | 2000-03-31 | 2001-10-11 | Sir Mortimer B. Davis Jewish General Hospital | Microchip arrays of regulatory genes |
| US6642003B2 (en) | 2001-08-02 | 2003-11-04 | Cedars-Sinai Medical Center | Human glucose-dependent insulin-secreting cell line |
| US7141240B2 (en) * | 2002-03-12 | 2006-11-28 | Cedars-Sinai Medical Center | Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
| US20060223807A1 (en) | 2005-03-29 | 2006-10-05 | University Of Massachusetts Medical School, A Massachusetts Corporation | Therapeutic methods for type I diabetes |
| US8080517B2 (en) * | 2005-09-12 | 2011-12-20 | Xigen Sa | Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| WO2007031098A1 (en) | 2005-09-12 | 2007-03-22 | Xigen S.A. | Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| WO2009143864A1 (en) * | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| WO2009143865A1 (en) | 2008-05-30 | 2009-12-03 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2010072228A1 (en) | 2008-12-22 | 2010-07-01 | Xigen S.A. | Novel transporter constructs and transporter cargo conjugate molecules |
| JP5457813B2 (ja) * | 2009-12-16 | 2014-04-02 | ルネサスエレクトロニクス株式会社 | Ａｄｐｌｌ回路、半導体装置及び携帯情報機器 |
| WO2011160653A1 (en) | 2010-06-21 | 2011-12-29 | Xigen S.A. | Novel jnk inhibitor molecules |
| CA2807036C (en) | 2010-10-14 | 2018-01-16 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| WO2013091670A1 (en) | 2011-12-21 | 2013-06-27 | Xigen S.A. | Novel jnk inhibitor molecules for treatment of various diseases |
| PL3013353T3 (pl) | 2013-06-26 | 2021-09-20 | Xigen Inflammation Ltd. | Przenikające do komórki inhibitory peptydowe szlaku przekazywania sygnału jnk do leczenia zapalenia pęcherza |
| WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995014772A1 (fr) * | 1993-11-12 | 1995-06-01 | Kenichi Matsubara | Signature genique |
-
1997
- 1997-05-20 US US08/859,201 patent/US5880261A/en not_active Expired - Lifetime
-
1998
- 1998-04-02 AT AT98913958T patent/ATE382087T1/de not_active IP Right Cessation
- 1998-04-02 WO PCT/GB1998/000972 patent/WO1998044106A1/en active IP Right Grant
- 1998-04-02 ES ES98913958T patent/ES2299205T3/es not_active Expired - Lifetime
- 1998-04-02 DE DE69838905T patent/DE69838905T2/de not_active Expired - Lifetime
- 1998-04-02 EP EP98913958A patent/EP0973895B1/de not_active Expired - Lifetime
- 1998-04-02 AT AT07019868T patent/ATE517993T1/de not_active IP Right Cessation
- 1998-04-02 EP EP07019868A patent/EP1889913B1/de not_active Expired - Lifetime
- 1998-04-02 DK DK98913958T patent/DK0973895T3/da active
- 1998-04-02 AU AU68472/98A patent/AU6847298A/en not_active Abandoned
- 1998-04-02 EP EP07008419A patent/EP1889912A1/de not_active Withdrawn
- 1998-04-02 PT PT98913958T patent/PT973895E/pt unknown
- 1998-04-02 US US09/402,214 patent/US6620914B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1889913A1 (de) | 2008-02-20 |
| US6620914B1 (en) | 2003-09-16 |
| ES2299205T3 (es) | 2008-05-16 |
| EP0973895A1 (de) | 2000-01-26 |
| EP1889913B1 (de) | 2011-07-27 |
| DE69838905T2 (de) | 2008-12-11 |
| PT973895E (pt) | 2008-01-29 |
| US5880261A (en) | 1999-03-09 |
| EP1889912A1 (de) | 2008-02-20 |
| ATE382087T1 (de) | 2008-01-15 |
| AU6847298A (en) | 1998-10-22 |
| DK0973895T3 (da) | 2008-04-28 |
| WO1998044106A1 (en) | 1998-10-08 |
| DE69838905D1 (de) | 2008-02-07 |
| EP0973895B1 (de) | 2007-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE382087T1 (de) | Transkriptionsfaktor islet-brain 1 (ib1) | |
| Gallagher et al. | The ARF tumour suppressor | |
| DE69733204D1 (de) | Neuartige vegf-ähnliche faktoren | |
| UA39161C2 (uk) | Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують | |
| DK478786A (da) | Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner | |
| ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
| WO2004053079A3 (en) | Compositions, splice variants and methods relating to ovarian specific genes and proteins | |
| DE60323231D1 (de) | Verkürzte tau proteine | |
| NZ531570A (en) | DNA sequences for human angiogenesis genes | |
| HK1095160A1 (en) | Use of fibroblast growth factor fragments | |
| ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
| WO2004050894A3 (en) | Heart failure gene determination and therapeutic screening | |
| HUP9903921A2 (hu) | Tumor nekrózis faktorral rokon ligandum | |
| PL350417A1 (en) | Vascular adhesion molecules and modulation of their function | |
| ATE294236T1 (de) | Promotor der tie rezeptor protein kinase | |
| WO2002088750A3 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
| DE69233507D1 (de) | Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten | |
| GB9924957D0 (en) | Novel treatment | |
| DE68923107D1 (de) | DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI. | |
| ATE88500T1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
| DE60044119D1 (de) | Reagentien und verfahren zur erkennung von erkrankungen der brust | |
| Bossak-Ahmad et al. | Ternary Cu2+ Complexes of Human Serum Albumin and Glycyl-l-histidyl-l-lysine | |
| ATE163651T1 (de) | Neues menschliches, rekombinantes interferon gamma | |
| DE69534705D1 (de) | Dickdarm spezifische gene und proteine | |
| WO2004050860A3 (en) | Compositions, splice variants and methods relating to colon specific genes and proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |